Rafferty Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $433K | Sell |
42,644
-34,780
| -45% | -$353K | ﹤0.01% | 913 |
|
|
2025
Q1 | $432K | Buy |
77,424
+26,032
| +51% | +$145K | ﹤0.01% | 898 |
|
|
2024
Q4 | $415K | Sell |
51,392
-13,193
| -20% | -$106K | ﹤0.01% | 948 |
|
|
2024
Q3 | $662K | Sell |
64,585
-51,623
| -44% | -$529K | ﹤0.01% | 879 |
|
|
2024
Q2 | $822K | Buy |
116,208
+5,062
| +5% | +$35.8K | ﹤0.01% | 858 |
|
|
2024
Q1 | $1.53M | Buy |
+111,146
| New | +$1.53M | 0.01% | 753 |
|
|
2022
Q1 | – | Sell |
-68,423
| Closed | -$1.01M | – | 1300 |
|
|
2021
Q4 | $1.01M | Buy |
68,423
+37,112
| +119% | +$546K | 0.01% | 857 |
|
|
2021
Q3 | $655K | Sell |
31,311
-16,323
| -34% | -$341K | ﹤0.01% | 983 |
|
|
2021
Q2 | $843K | Sell |
47,634
-19,730
| -29% | -$349K | 0.01% | 965 |
|
|
2021
Q1 | $1.65M | Buy |
+67,364
| New | +$1.65M | 0.01% | 674 |
|